Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV005295287 | SCV005959411 | uncertain significance | Inborn genetic diseases | 2024-12-12 | criteria provided, single submitter | clinical testing | The c.5029G>A (p.V1677M) alteration is located in exon 23 (coding exon 23) of the TUBGCP6 gene. This alteration results from a G to A substitution at nucleotide position 5029, causing the valine (V) at amino acid position 1677 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |